InvestorsHub Logo
Followers 0
Posts 161
Boards Moderated 0
Alias Born 03/31/2014

Re: gi197845 post# 541

Sunday, 04/19/2020 4:05:12 PM

Sunday, April 19, 2020 4:05:12 PM

Post# of 785
I think it is very good news and also thinks it played a role in the LPCNs most recent CRL. Why would Clarus get its product approved while missing a few of the secondary endpoints and then petition the FDA not to approve any other oral T medications if they miss secondary endpoints? It makes no sense to me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LPCN News